Summary:
A randomized, parallel-arm, double-blinded study comparing the effect of once-weekly Dulaglutide with placebo in patients with Type 2 Diabetes Mellitus on Sulfonylurea Therapy.
Qualified Participants Must:
• Have uncontrolled Type 2 Diabetes
•
Be 18 years of age, or older
•
Have had a stable weight for the last 3 months.
•
Be taking a Sulfonylurea only for their Diabetes.
Qualified Participants May Receive:
Study Diabetic once weekly medication, study supplies, study related medical care and compensation for time and travel.